Related Experiment Video

Updated: Oct 21, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Therapeutic drug monitoring opportunities in cancer therapy

H L McLeod1

  • 1Department of Medicine and Therapeutics, University of Aberdeen, UK.

Pharmacology & Therapeutics
|January 1, 1997
PubMed

Insights

Therapeutic drug monitoring can improve cancer treatment by accounting for individual patient variations in drug levels. This approach helps optimize drug effectiveness and minimize toxicity for better patient outcomes.

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Pharmacy

Background:

  • Cancer remains a leading cause of mortality globally, necessitating advancements in treatment strategies.
  • Significant inter-individual variability exists in systemic drug exposure, impacting treatment efficacy and toxicity.
  • The relationship between drug blood concentrations and clinical effects (toxic or antitumor) supports personalized medicine approaches.

Purpose of the Study:

  • To review the evidence supporting therapeutic drug monitoring (TDM) for commonly used cancer medications.
  • To identify specific cancer drugs and clinical scenarios where TDM could enhance patient treatment.
  • To highlight areas requiring further research and development in cancer drug monitoring.

Main Methods:

  • Systematic literature review of studies investigating therapeutic drug monitoring in oncology.
  • Analysis of pharmacokinetic and pharmacodynamic data for selected anticancer agents.
  • Evaluation of the correlation between drug concentrations and treatment outcomes (efficacy and toxicity).

Main Results:

  • Evidence supports the use of TDM for several frequently prescribed cancer drugs.
  • Variability in drug exposure significantly influences treatment response and adverse events.
  • Optimizing drug concentrations through TDM can potentially improve therapeutic outcomes.

Conclusions:

  • Therapeutic drug monitoring offers a viable strategy to personalize cancer therapy and improve patient outcomes.
  • Further research is needed to expand the application of TDM to a broader range of anticancer drugs.
  • Implementing TDM requires a concerted effort in clinical practice and research to overcome existing challenges.

More Related Videos

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...